English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Tabitha Fleming
| Jun 2, 2017
European Commission approves dinutuximab beta for treating high-risk neuroblastoma
Tabitha Fleming
| Jun 2, 2017
Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe
Tabitha Fleming
| May 26, 2017
National Institute on Alcohol Abuse and Alcoholism releases 5-year action plan
Tabitha Fleming
| May 26, 2017
American Academy of Family Physicians supports guidelines for osteoporosis treatment
Tabitha Fleming
| May 25, 2017
Nautilus Medical working to increase patient access to radiology reports
Tabitha Fleming
| May 14, 2017
Lupus Foundation of America promotes awareness of disease
Tabitha Fleming
| Mar 10, 2017
Genetic engineering could make jeans cheaper to produce
Tabitha Fleming
| Mar 1, 2017
Utah, Lousiana issue standing order for opioid overdose drug
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
1
2
»
Last »